Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Aldosterone levels undetectably low in hospitalized COVID-19 patients

Aldosterone levels undetectably low in hospitalized COVID-19 patients

Omicron-specific mRNA vaccine generates immune responses in mice, hamsters and Macaques

Omicron-specific mRNA vaccine generates immune responses in mice, hamsters and Macaques

Longitudinal analysis of CD4+ T cells and antibody responses to common cold coronaviruses

Longitudinal analysis of CD4+ T cells and antibody responses to common cold coronaviruses

Study does not find association between hematological parameters and COVID-19-related hospitalization

Study does not find association between hematological parameters and COVID-19-related hospitalization

Dynamics of SARS-CoV-2 transmission at Purdue University

Dynamics of SARS-CoV-2 transmission at Purdue University

Patterns of bat β-coronaviruses evolution

Patterns of bat β-coronaviruses evolution

Gas chromatography-ion mobility spectrometry helps diagnose COVID-19 and predict disease severity

Gas chromatography-ion mobility spectrometry helps diagnose COVID-19 and predict disease severity

RT-LAMP assay shows promise as point-of-care SARS-CoV-2 detection assay across multiple settings

RT-LAMP assay shows promise as point-of-care SARS-CoV-2 detection assay across multiple settings

Angiotensin-converting enzyme 2-based mutant decoy effectively reduces COVID-19 in mice

Angiotensin-converting enzyme 2-based mutant decoy effectively reduces COVID-19 in mice

Clinical trial report endorses nitazoxanide as a safe drug for moderately ill COVID-19 patients

Clinical trial report endorses nitazoxanide as a safe drug for moderately ill COVID-19 patients

Convalescent plasma therapy shows no significant impact on COVID-19 recovery and outcomes

Convalescent plasma therapy shows no significant impact on COVID-19 recovery and outcomes

8G3 broad-spectrum antibody effective against all SARS-CoV-2 variants, including Omicron

8G3 broad-spectrum antibody effective against all SARS-CoV-2 variants, including Omicron

Incidence and outcomes of breakthrough SARS-CoV-2 infections in vaccinated chronic liver disease patients

Incidence and outcomes of breakthrough SARS-CoV-2 infections in vaccinated chronic liver disease patients

Study shows targeting DDX3 with RK-33 reduced the viral load in four isolates of SARS-CoV-2

Study shows targeting DDX3 with RK-33 reduced the viral load in four isolates of SARS-CoV-2

Study establishes that a low dose SARS-CoV-2 infection increases risk of pneumococcal coinfection

Study establishes that a low dose SARS-CoV-2 infection increases risk of pneumococcal coinfection

The benefits of using fractional doses of COVID-19 vaccines

The benefits of using fractional doses of COVID-19 vaccines

First dose SARS-CoV-2 vaccination coverage among younger children in America

First dose SARS-CoV-2 vaccination coverage among younger children in America

Infection with Omicron sub-lineage BA.1 protects from reinfection against BA.2 sub-lineage and vice-versa

Infection with Omicron sub-lineage BA.1 protects from reinfection against BA.2 sub-lineage and vice-versa

Study explores coronavirus surveillance in bats from Argentina

Study explores coronavirus surveillance in bats from Argentina

Multigranular and visualization approach precisely predicts SARS-CoV-2 outcomes

Multigranular and visualization approach precisely predicts SARS-CoV-2 outcomes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.